X

Xencor
D

XNCR

19.240
USD
-0.78
(-3.90%)
مغلق
حجم التداول
16,539
الربح لكل سهم
-1
العائد الربحي
-
P/E
-6
حجم السوق
1,346,454,257
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    AMGN
    AMGN
    2.84
    (1.05%)
    272.25 USD
    BIIB
    BIIB
    -0.660
    (-0.47%)
    140.580 USD
    B
    BLUE
    0.05000
    (0.60%)
    8.35000 USD
    B
    BMRN
    0.260
    (0.42%)
    61.570 USD
    C
    CLDT
    0.02700
    (0.31%)
    8.82700 USD
    GILD
    GILD
    0.150
    (0.16%)
    91.790 USD
    ILMN
    ILMN
    -0.725
    (-0.53%)
    136.625 USD
    I
    INCY
    -0.500
    (-0.69%)
    71.950 USD
    REGN
    REGN
    -11.37
    (-1.64%)
    681.49 USD
    T
    TGTX
    0.380
    (1.30%)
    29.530 USD
    المزيد
الأخبار
المقالات

العنوان: Xencor

القطاع: Healthcare
الصناعة: Biotechnology
Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases such with unmet medical needs. The company uses its XmAb technology platform to create antibody product candidates such as XmAb5871 and XmAb7195. It also has a few pre-clinical stage candidates in its portfolio such as XmAb14045, XmAb662 among others. It earns its revenue from research and development collaborations and licenses of its internally developed drug candidates.